On June 3, 2025, the Journal of Clinical Oncology published a study funded by Johnson & Johnson, which showed that one-third of patients with relapsed/refractory multiple myeloma who were treated with CARVYKTI®...more
On March 20, 2024, The USPTO issued an alert, notifying practitioners that the USPTO had developed training materials for patent examiners regarding searching for prior art in FDA and NIH databases. ...more
3/25/2024
/ Biotechnology ,
Food and Drug Administration (FDA) ,
Healthcare ,
Intellectual Property Protection ,
National Institute of Health (NIH) ,
Over The Counter Drugs (OTC) ,
Patent Examinations ,
Pharmaceutical Industry ,
Prescription Drugs ,
Prior Art ,
Training Requirements ,
USPTO